These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9808534)

  • 1. Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis.
    Goss KJ; Brown PD; Matrisian LM
    Int J Cancer; 1998 Nov; 78(5):629-35. PubMed ID: 9808534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase inhibitors.
    Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
    Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation.
    Chavey C; Mari B; Monthouel MN; Bonnafous S; Anglard P; Van Obberghen E; Tartare-Deckert S
    J Biol Chem; 2003 Apr; 278(14):11888-96. PubMed ID: 12529376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice.
    Low JA; Johnson MD; Bone EA; Dickson RB
    Clin Cancer Res; 1996 Jul; 2(7):1207-14. PubMed ID: 9816289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice.
    Sledge GW; Qulali M; Goulet R; Bone EA; Fife R
    J Natl Cancer Inst; 1995 Oct; 87(20):1546-50. PubMed ID: 7563189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat.
    Holst-Hansen C; Low JA; Stephens RW; Johnson MD; Carmeliet P; Frandsen TL; Brünner N; Dickson RB
    Breast Cancer Res Treat; 2001 Aug; 68(3):225-37. PubMed ID: 11727959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase inhibitors: a novel class of anticancer agents.
    Brown PD
    Adv Enzyme Regul; 1995; 35():293-301. PubMed ID: 7572350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer.
    Zervos EE; Shafii AE; Rosemurgy AS
    J Surg Res; 1999 Jan; 81(1):65-8. PubMed ID: 9889060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
    Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
    Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.
    Giavazzi R; Garofalo A; Ferri C; Lucchini V; Bone EA; Chiari S; Brown PD; Nicoletti MI; Taraboletti G
    Clin Cancer Res; 1998 Apr; 4(4):985-92. PubMed ID: 9563894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats.
    Aparicio T; Kermorgant S; Dessirier V; Lewin MJ; Lehy T
    Carcinogenesis; 1999 Aug; 20(8):1445-51. PubMed ID: 10426790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases.
    Taraboletti G; Garofalo A; Belotti D; Drudis T; Borsotti P; Scanziani E; Brown PD; Giavazzi R
    J Natl Cancer Inst; 1995 Feb; 87(4):293-8. PubMed ID: 7535861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
    Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells.
    Páez Pereda M; Ledda MF; Goldberg V; Chervín A; Carrizo G; Molina H; Müller A; Renner U; Podhajcer O; Arzt E; Stalla GK
    J Clin Endocrinol Metab; 2000 Jan; 85(1):263-9. PubMed ID: 10634397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
    Afzal S; Lalani el-N ; Foulkes WD; Boyce B; Tickle S; Cardillo MR; Baker T; Pignatelli M; Stamp GW
    Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of stromal matrix metalloproteases: effects on breast-tumor promotion by fibroblasts.
    Noël A; Hajitou A; L'Hoir C; Maquoi E; Baramova E; Lewalle JM; Remacle A; Kebers F; Brown P; Calberg-Bacq CM; Foidart JM
    Int J Cancer; 1998 Apr; 76(2):267-73. PubMed ID: 9537590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo.
    Zervos EE; Norman JG; Gower WR; Franz MG; Rosemurgy AS
    J Surg Res; 1997 May; 69(2):367-71. PubMed ID: 9224409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases of human NK cells.
    Albertsson P; Kim MH; Jonges LE; Kitson RP; Kuppen PJ; Johansson BR; Nannmark U; Goldfarb RH
    In Vivo; 2000; 14(1):269-76. PubMed ID: 10757086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrilysin in early stage intestinal tumorigenesis.
    Fingleton BM; Heppner Goss KJ; Crawford HC; Matrisian LM
    APMIS; 1999 Jan; 107(1):102-10. PubMed ID: 10190286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Batimastat. BB 94, collagenase inhibitors-1.
    Drugs R D; 1999 Feb; 1(2):139-41. PubMed ID: 10566008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.